<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058504</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hepatic involvement in coeliac disease</dc:title>
<dc:description xml:lang="en">Celiac disease (CD) is an autoimmune enteropathy triggered by gluten ingestion in genetically susceptible individuals. Hypertransaminasemia has been observed in up to 40% of untreated celiac patients and is usually resolved by a gluten-free diet. The most common type of liver disease associated with CD is non-specific reactive hepatitis, while association with viral hepatitis or autoimmune-mediated liver diseases such as autoimmune hepatitis, primary biliary cirrhosis or primary sclerosing cholangitis is less frequent. Therefore, a practical recommendation would be to look for liver disfunction in patients with CD as well as to perform diagnostic tests for CD in patients with hypertransaminasemia or cholestasis of unknown etiology</dc:description>
<dc:creator>Moreno Monteagudo, José Andrés</dc:creator>
<dc:creator>Moreno Otero, Ricardo</dc:creator>
<dc:creator>Moreno Borque, Ricardo</dc:creator>
<dc:creator>Barbero Villares, Almudena</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enfermedad celíaca (EC) es una enteropatía autoinmune desencadenada por la ingestión de gluten en individuos con susceptibilidad genética. Se ha observado la existencia de una hipertransaminasemia en aproximadamente el 40% de los pacientes celíacos no tratados, que suele resolverse al excluir el gluten de la dieta. La forma más frecuente de afectación hepática en estos pacientes es una hepatitis reactiva inespecífica, y es menos común su asociación con las hepatitis virales o las hepatopatías autoinmunes, como la hepatitis autoinmune, la cirrosis biliar primaria o la colangitis esclerosante primaria. Por tanto, sería recomendable la búsqueda de hepatopatía en enfermos celíacos y, de igual modo, la realización de pruebas diagnósticas de EC en pacientes con hipertransaminasemia o colestasis de causa no filiada</dc:description>
<dc:source>Gastroenterol Hepatol;31(1): 25-28, ene.2008. ilus</dc:source>
<dc:identifier>ibc-058504</dc:identifier>
<dc:title xml:lang="es">Afectación hepática en la enfermedad celíaca</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d1333^s22012</dc:subject>
<dc:subject>^d2829^s22027</dc:subject>
<dc:subject>^d23585^s22080</dc:subject>
<dc:subject>^d650^s22002</dc:subject>
<dc:subject>^d8281^s22027</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2481^s22012</dc:subject>
<dc:subject>^d33349^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200801</dc:date>
</metadata>
</record>
</ibecs-document>
